Skip to main content
Top
Appendix
Available only for authorised users
Literature
2.
go back to reference Alaggio R, Amador-Ortiz C, Anagnostopoulos I, Attygalle A, Araújo I, Berti E, Bhagat G, Borges A, Boyer DF, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng W, Choi JK, Chuang S, Coupland SE, Czader M, Davé SS, De Jong D, Du M, Elenitoba-Johnson KSJ, Ferry JA, Geyer JT, Gratzinger D, Guitart J, Gujral S, Harris MH, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury JD, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li X-Q, Lim MS, Liu W-P, Louissaint A, Marcogliese AN, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes‐Moreno S, Morice WG, Nardi V, Naresh KN, Natkunam Y, Ng S, Oschlies I, Ott G, Parrens M-C, Pulitzer M, Rajkumar SV, Rawstron AC, Rech KL, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell WA, Siebert R, Sohani AR, Tooze R, Traverse‐Glehen A, Vega F, Vergier B, Wechalekar AD, Wood BL, Xerri L, Xiao W (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 36:1720–1748. https://doi.org/10.1038/s41375-022-01620-2 Alaggio R, Amador-Ortiz C, Anagnostopoulos I, Attygalle A, Araújo I, Berti E, Bhagat G, Borges A, Boyer DF, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng W, Choi JK, Chuang S, Coupland SE, Czader M, Davé SS, De Jong D, Du M, Elenitoba-Johnson KSJ, Ferry JA, Geyer JT, Gratzinger D, Guitart J, Gujral S, Harris MH, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury JD, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li X-Q, Lim MS, Liu W-P, Louissaint A, Marcogliese AN, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes‐Moreno S, Morice WG, Nardi V, Naresh KN, Natkunam Y, Ng S, Oschlies I, Ott G, Parrens M-C, Pulitzer M, Rajkumar SV, Rawstron AC, Rech KL, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell WA, Siebert R, Sohani AR, Tooze R, Traverse‐Glehen A, Vega F, Vergier B, Wechalekar AD, Wood BL, Xerri L, Xiao W (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 36:1720–1748. https://​doi.​org/​10.​1038/​s41375-022-01620-2
Metadata
Title
Lymphoid Proliferations and Lymphoma Associated with Immune Deficiency, and Dysregulation in a Patient Treated with Cyclosporine Monotherapy for Psoriasis
Authors
Toshiyuki Nakanishi
Satoshi Noto
Yusuke Nakamichi
Mori Nakai
Naoki Takezako
Publication date
01-05-2024
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-024-01781-3
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine